skip to content
- Graeme Alexander, Cambridge University Hospital NHS Foundation Trust
- Susan Barnett and colleagues, Novartis Vaccines and Diagnostics
- Helen Baxendale, Consultant Immunologist Papworth Hospital
- William Bernal, Kings College London, UK
- Mario Caccamo & Richard Leggett, TGAC, Norwich
- Martin Curran, Suzy English, HPA Addenbrookes, Cambridge
- Ranier Doffinger, Dept of Clinical Biochemistry and Immunology, Addenbrooke's
- Mariano Esteban, Centro Nacional de Biotecnologia, Madrid, Spain
- Genoveffa Franchini, Vaccine Branch, NIH, NCI, Bethesda
- Steven Holland, Lab of Clinical Infectious Diseases, NIAID, NIH Bethesda
- Leo James, LMB, Cambridge
- Paul Kellam, Julian Parkhill and Gordon Dougan, Wellcome Trust Sanger Institute, Hinxton, Cambridge
- Dinakantha Kumararatne, Consultant Immunologist, Addenbrooke's Hospital
- Paul Lehner, Gillian Griffiths, CIMR, Cambridge
- Peter Liljestrom, Karolinska Institutet, Stockholm, Sweden
- Sheena McCormack, Clinical Trial Unit, London, UK
- Giuseppe Pantaleo, CHUV, Lausanne, Switzerland
- Quentin Sattentau, University of Oxford
- Ken Smith, Paul Lyons, Department of Medicine, University of Cambridge
- Mahima Swamy, U of Dundee and Adrian Hayday, King's College, London
- Marc Veldhoen, BBSRC Babraham Institute, Cambridge
- Ralf Wagner, University of Regensburg, Germany
- Jonathan Weber, Imperial College London, UK
- Robin Weiss, University College London, UK
- Winifred Weissenhorn, Joseph Fourier University, Grenoble, France
- Ed Wright, Westminster University, London, UK
